ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 26 filers reported holding ENVVENO MEDICAL CORPORATION in Q4 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,212,905 | +75.0% | 781,615 | 0.0% | 0.14% | +101.4% |
| Q2 2023 | $2,407,374 | -34.2% | 781,615 | 0.0% | 0.07% | -35.2% |
| Q1 2023 | $3,657,958 | -8.2% | 781,615 | 0.0% | 0.11% | -3.6% |
| Q4 2022 | $3,986,236 | -18.8% | 781,615 | 0.0% | 0.11% | -21.1% |
| Q3 2022 | $4,909,000 | +66.2% | 781,615 | 0.0% | 0.14% | +52.7% |
| Q2 2022 | $2,954,000 | -40.7% | 781,615 | 0.0% | 0.09% | -7.0% |
| Q1 2022 | $4,978,000 | -51.7% | 781,615 | -50.0% | 0.10% | +26.6% |
| Q4 2021 | $10,300,000 | – | 1,563,230 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
| Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
| Kepos Capital LP | 50,000 | $319,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |